DexTech Medical AB (XSAT:DEX) E10: kr-0.49 (As of Mar. 2026)


XSAT:DEX DexTech Medical AB XSAT:DEX
32 GF Score
Price kr10.60
! 3 Warning Signs
View Full Analysis

What is DexTech Medical AB E10?

DexTech Medical AB XSAT:DEX +2.91% 32 E10 is kr-0.49 as of Mar. 2026. GuruFocus rates XSAT:DEX with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

DexTech Medical AB's adjusted earnings per share data for the three months ended in Mar. 2026 was kr-0.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-0.49 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), DexTech Medical AB's current stock price is kr10.60. DexTech Medical AB's E10 for the quarter that ended in Mar. 2026 was kr-0.49. DexTech Medical AB's Shiller PE Ratio of today is .


DexTech Medical AB  (XSAT:DEX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


DexTech Medical AB E10 Related Terms


DexTech Medical AB E10 Historical Data

* Premium members only.

The historical data trend for DexTech Medical AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexTech Medical AB E10 Chart

DexTech Medical AB Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.52 -0.53 -0.50

DexTech Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.51 -0.50 -0.50 -0.50 -0.49

XSAT:DEX vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, DexTech Medical AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexTech Medical AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DexTech Medical AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where DexTech Medical AB's Shiller PE Ratio falls into.


XSAT:DEX
32GF Score
DexTech Medical AB XSAT:DEX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexTech Medical AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DexTech Medical AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.09/133.3862*133.3862
=-0.090

Current CPI (Mar. 2026) = 133.3862.

DexTech Medical AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.146 101.019 -0.193
201609 -0.107 101.138 -0.141
201612 -0.137 102.022 -0.179
201703 -0.137 102.022 -0.179
201706 -0.205 102.752 -0.266
201709 -0.127 103.279 -0.164
201712 -0.146 103.793 -0.188
201803 -0.146 103.962 -0.187
201806 -0.168 104.875 -0.214
201809 -0.127 105.679 -0.160
201812 -0.157 105.912 -0.198
201903 -0.127 105.886 -0.160
201906 -0.147 106.742 -0.184
201909 -0.127 107.214 -0.158
201912 -0.127 107.766 -0.157
202003 -0.127 106.563 -0.159
202006 -0.127 107.498 -0.158
202009 -0.098 107.635 -0.121
202012 -0.100 108.296 -0.123
202103 -0.100 108.360 -0.123
202106 -0.100 108.928 -0.122
202109 -0.060 110.338 -0.073
202112 -0.080 112.486 -0.095
202203 -0.060 114.825 -0.070
202206 -0.111 118.384 -0.125
202209 -0.040 122.296 -0.044
202212 -0.060 126.365 -0.063
202303 -0.080 127.042 -0.084
202306 -0.060 129.407 -0.062
202309 -0.050 130.224 -0.051
202312 -0.060 131.912 -0.061
202403 -0.080 132.205 -0.081
202406 -0.070 132.716 -0.070
202409 -0.060 132.304 -0.060
202412 -0.050 132.987 -0.050
202503 -0.070 132.825 -0.070
202506 -0.080 133.699 -0.080
202509 -0.070 133.482 -0.070
202512 -0.090 133.386 -0.090
202603 -0.090 133.386 -0.090

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-0.49 mean?
DexTech Medical AB (XSAT:DEX) has a E10 of kr-0.49 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on DexTech Medical AB and its competitors.
Is DexTech Medical AB's E10 too high?
DexTech Medical AB's current E10 is kr-0.49. Overall, DexTech Medical AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does DexTech Medical AB's E10 compare to VRTX and REGN?
DexTech Medical AB's E10 of kr-0.49 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on DexTech Medical AB and its competitors. DexTech Medical AB's current E10 is kr-0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexTech Medical AB stock overvalued right now?
DexTech Medical AB (XSAT:DEX) has a current E10 of kr-0.49. The current E10 is kr-0.49. DexTech Medical AB's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For DexTech Medical AB (XSAT:DEX), the current E10 is kr-0.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DexTech Medical AB Business Description

Address Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
32GF Score

Get the complete analysis for XSAT:DEX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.60
Price